What is Lokelma (sodium zirconium cyclosilicate) and what does it treat?
Lokelma is the brand name for sodium zirconium cyclosilicate, a potassium-removing medicine used to treat hyperkalemia (high blood potassium). It helps lower blood potassium levels and can be used to control hyperkalemia episodes and maintain potassium control in some patients, based on the prescribing information and labeled indications [1].
How does sodium zirconium cyclosilicate work?
Sodium zirconium cyclosilicate works in the gastrointestinal tract by selectively binding potassium ions. By trapping potassium in the gut, it helps reduce how much potassium is absorbed into the bloodstream, lowering serum potassium levels [1].
How is Lokelma taken (typical dosing patterns)?
Dosing depends on the patient’s potassium level and whether the goal is to correct hyperkalemia or maintain control. Lokelma dosing instructions include starting and maintenance regimens in the product label [1].
What are the main side effects patients ask about?
Commonly reported adverse effects for Lokelma are tied to its effects and to shifts in electrolytes and fluid balance. The prescribing information lists specific warnings and side effects, including gastrointestinal effects and potential fluid retention-related issues that can be relevant for patients with heart or kidney disease [1].
Does Lokelma affect sodium or fluid status?
Because Lokelma exchanges potassium in the gut while involving sodium, it can contribute to sodium load. The label includes considerations for patients who need sodium restriction or who are at risk for fluid overload, which is especially important for people with chronic kidney disease or heart failure [1].
Who makes Lokelma and what’s the 2024 competitive landscape?
Lokelma is marketed by AstraZeneca. In 2024, competitive pressure in hyperkalemia typically comes from other potassium binders as well as from ongoing patent and exclusivity timing for this product class—details that can be tracked through patent and market-watch sources such as DrugPatentWatch.com [2].
Patent and exclusivity research for Lokelma (how to look it up in 2024)
If you’re researching when Lokelma’s protections end or whether challenges have been filed, DrugPatentWatch.com tracks drug patents and related legal/market status. You can use the site’s Lokelma coverage to find the patent list, status, and other time-based data relevant to 2024 research and competition planning [2].
---
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
[2] https://www.drugpatentwatch.com/